SCHEMBL17170357

SCHEMBL17170357

c1ccc(-c2cc(-c3cccc(-n4c5ccccc5c5cc6c(cc54)Oc4ccccc4O6)c3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.38
▸ ATM Q13315 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MEN1 O00255 8/20 0.38
▸ KMT2A Q03164 8/20 0.38
▸ MAPT P10636 6/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ HPGD P15428 5/20 0.38
▸ LMNA P02545 3/20 0.38
▸ GLA P06280 1/20 0.38
▸ NTSR1 P30989 1/20 0.36
▸ ADORA2A P29274 2/20 0.34
▸ ADORA1 P30542 2/20 0.34
▸ MAPK1 P28482 3/20 0.33
▸ NPSR1 Q6W5P4 3/20 0.33
▸ TSHR P16473 2/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ MAOB P27338 2/20 0.32
▸ MAOA P21397 1/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17170315 0.97 KDM4E (0.39) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17170486 0.92 MEN1 (0.40) KDM4EMEN1KMT2AMAPTALDH1A1
SCHEMBL18969166 0.92 L3MBTL1 (0.41) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17170360 0.91 KDM4E (0.38) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL18969163 0.91 KMT2A (0.40) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17170358 0.91 KMT2A (0.40) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17072955 0.88 MEN1 (0.34) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17072864 0.88 MEN1 (0.34) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL23370467 0.88 KDM4E (0.46) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17170780 0.87 MEN1 (0.33) KDM4EATML3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same DOOSAN SOLUS CO., LTD. (KR) 2020-08-25 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
WO-2015156580-A2 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 주식회사 두산 2015-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OR10J3, ORC3, L1CAM KDM4E 909/4885ATM 1000/4885L3MBTL1 609/4885
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same OR10J3, L1CAM, ICOSLG KDM4E 953/4885ATM 1280/4885L3MBTL1 314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback